Yongmei Yin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yongmei Yin has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
- Rimo Xi
State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and KLMDASR of Tianjin, Nankai University, Tongyan Road, Haihe Education Park, Tianjin 300350, China
20 shared publications Meng Meng
State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin, 300353, China
16 shared publications- Meng Meng
State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and KLMDASR of Tianjin, Nankai University, Tongyan Road, Haihe Education Park, Tianjin 300350, China
9 shared publications Qian Liu
State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin, 300353, China
7 shared publications- Xiujie Zhao
Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China
7 shared publications Yan Ma
State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and KLMDASR of Tianjin, Nankai University, Tongyan Road, Haihe Education Park, Tianjin 300350, China
6 shared publications
Latest Publications
- 22 June 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 317, 119076
Rationally designed tetrasaccharide inhibitors of heparanase with anti-inflammatory activity and protective effects in sepsis
- 22 June 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 317, 119076
Rationally designed tetrasaccharide inhibitors of heparanase with anti-inflammatory activity and protective effects in sepsis
- 2 June 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (23) , 7428-7432
Dual Innovations Driving Pseudomonas aeruginosa Lipopolysaccharide Core Pentasaccharide Synthesis: Linker Configuration Control and One-Pot Bis-glycosylation
Pseudomonas aeruginosa is a clinically common multidrug-resistant pathogen that causes infections with high mortality and great treatment difficulty. This study achieved two key innovations: precise α/β configuration control of d-GalpN3, d-GlcpN3, d-QuipN3, and d-FucpN3 sugar-linker compounds and an innovative one-pot bis-glycosylation strategy, successfully completing the total synthesis of its LPS outer core pentasaccharide (a key vaccine antigen). This work provides a promotable methodological framework for the precise synthesis of complex bacterial oligosaccharides.
- 2 June 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (23) , 7428-7432
Dual Innovations Driving Pseudomonas aeruginosa Lipopolysaccharide Core Pentasaccharide Synthesis: Linker Configuration Control and One-Pot Bis-glycosylation
Pseudomonas aeruginosa is a clinically common multidrug-resistant pathogen that causes infections with high mortality and great treatment difficulty. This study achieved two key innovations: precise α/β configuration control of d-GalpN3, d-GlcpN3, d-QuipN3, and d-FucpN3 sugar-linker compounds and an innovative one-pot bis-glycosylation strategy, successfully completing the total synthesis of its LPS outer core pentasaccharide (a key vaccine antigen). This work provides a promotable methodological framework for the precise synthesis of complex bacterial oligosaccharides.
- 6 May 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (19) , 19995-20009
In Vivo Metabolic Engineering of Bladder Cancer-Derived Extracellular Vesicles for Noninvasive Cancer Detection
Early and precise diagnosis of bladder cancer (BC) is crucial for improving patient prognosis. BC-derived extracellular vesicles (BC-EVs), which carry specific molecular information from their parent tumor cells, are directly released into the urine to serve as noninvasive liquid biopsy targets. However, the clinical utility of BC-EVs is largely hindered by their low urinary abundance and high interference from massive nontumor EVs. To overcome this barrier, we present an in vivo metabolic engineering strategy for BC-EVs with a tumor-targeting reactive oxygen species (ROS)-responsive micelle probe. These smart probes specifically accumulate in bladder tumors and release azide-choline in response to the oxidative microenvironment, covalently incorporating azide moieties into nascent BC-EV membranes. Upon secretion into urine, these chemically tagged EVs are selectively enriched for precise BC diagnosis via bioorthogonal click chemistry, thereby effectively eliminating background interference. Crucially, this platform is able to distinguish nonmuscle-invasive BC from muscle-invasive BC based on the profiled biomarkers. This metabolic programming strategy can be extended to other diseases by simply changing the targeting and recognition moieties.
- 6 May 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (19) , 19995-20009
In Vivo Metabolic Engineering of Bladder Cancer-Derived Extracellular Vesicles for Noninvasive Cancer Detection
Early and precise diagnosis of bladder cancer (BC) is crucial for improving patient prognosis. BC-derived extracellular vesicles (BC-EVs), which carry specific molecular information from their parent tumor cells, are directly released into the urine to serve as noninvasive liquid biopsy targets. However, the clinical utility of BC-EVs is largely hindered by their low urinary abundance and high interference from massive nontumor EVs. To overcome this barrier, we present an in vivo metabolic engineering strategy for BC-EVs with a tumor-targeting reactive oxygen species (ROS)-responsive micelle probe. These smart probes specifically accumulate in bladder tumors and release azide-choline in response to the oxidative microenvironment, covalently incorporating azide moieties into nascent BC-EV membranes. Upon secretion into urine, these chemically tagged EVs are selectively enriched for precise BC diagnosis via bioorthogonal click chemistry, thereby effectively eliminating background interference. Crucially, this platform is able to distinguish nonmuscle-invasive BC from muscle-invasive BC based on the profiled biomarkers. This metabolic programming strategy can be extended to other diseases by simply changing the targeting and recognition moieties.
- 3 November 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (45) , 25223-25231
Controllable Self-Assembly of Amphiphilic Heptamethine Cyanines for Turn-On Fluorescence-Guided Tumor Phototherapy
Heptamethine cyanines are attractive NIR fluorophores for image-guided tumor phototherapy. However, most cyanines exhibit unignorably high background fluorescence, which would lead to low-contrast images in the tumor. Inspired by findings that proper modulations of cyanines can self-quench fluorescence in the aggregated state but retrieve fluorescence when they are switched to the monomer, we herein engineer four amphiphilic heptamethine cyanines (IR780-NCn, n = 3/6/12/18) with extended hydrophobic alkyl chains. By studying the optimal properties and morphology of the dyes, we finally optimize IR780-NC12 and IR780-NC18 which can form nonfluorescent nanoaggregates in PBS but disassemble and recover intense NIR emission in hydrophobic media. Upon cellular uptake, the amphiphilic cyanines show fluorescence in membranous organelles such as mitochondria (IR780-NC3 and IR780-NC6) or the cell membrane (IR780-NC12 and IR780-NC18). Also, hydrophobic shielding enhances ROS generation under laser irradiation, as observed in IR780-NC12 and IR780-NC18. In vivo, IR780-NC18 administration (i.v.) exhibits the brightest and most prolonged tumor fluorescence up to 96 h. Guided by the NIR images in the tumor, an efficient PTT/PDT antitumor effect is confirmed for IR780-NC12 and IR780-NC18 phototherapy. We believe that self-assembly tuning design is a simple and powerful strategy to develop fluorescent "turn-on" cyanines as high-contrast NIR theranostic agents to guide tumor phototherapy.
- 3 November 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (45) , 25223-25231
Controllable Self-Assembly of Amphiphilic Heptamethine Cyanines for Turn-On Fluorescence-Guided Tumor Phototherapy
Heptamethine cyanines are attractive NIR fluorophores for image-guided tumor phototherapy. However, most cyanines exhibit unignorably high background fluorescence, which would lead to low-contrast images in the tumor. Inspired by findings that proper modulations of cyanines can self-quench fluorescence in the aggregated state but retrieve fluorescence when they are switched to the monomer, we herein engineer four amphiphilic heptamethine cyanines (IR780-NCn, n = 3/6/12/18) with extended hydrophobic alkyl chains. By studying the optimal properties and morphology of the dyes, we finally optimize IR780-NC12 and IR780-NC18 which can form nonfluorescent nanoaggregates in PBS but disassemble and recover intense NIR emission in hydrophobic media. Upon cellular uptake, the amphiphilic cyanines show fluorescence in membranous organelles such as mitochondria (IR780-NC3 and IR780-NC6) or the cell membrane (IR780-NC12 and IR780-NC18). Also, hydrophobic shielding enhances ROS generation under laser irradiation, as observed in IR780-NC12 and IR780-NC18. In vivo, IR780-NC18 administration (i.v.) exhibits the brightest and most prolonged tumor fluorescence up to 96 h. Guided by the NIR images in the tumor, an efficient PTT/PDT antitumor effect is confirmed for IR780-NC12 and IR780-NC18 phototherapy. We believe that self-assembly tuning design is a simple and powerful strategy to develop fluorescent "turn-on" cyanines as high-contrast NIR theranostic agents to guide tumor phototherapy.
- 24 June 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 287, 117714
Ferrocene derivatives constructed Prussian blue analogs for colorimetric detection of hydrogen peroxide and glucose
- 24 June 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 287, 117714
Ferrocene derivatives constructed Prussian blue analogs for colorimetric detection of hydrogen peroxide and glucose
- 17 June 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (25) , 6855-6861
Total Synthesis of the Conjugation-Ready Tetrasaccharide Repeating Unit of Acinetobacter baumannii MAR13-1452 (K125) Capsular Polysaccharide for Vaccine Development
Acinetobacter baumannii is a highly drug-resistant pathogen that causes severe hospital infections and urgently requires new treatment strategies. Surface-exposed glycans of these bacteria have emerged as promising vaccine targets due to their immunogenic potential. Here, we report the first total synthesis of the tetrasaccharide repeating unit of Acinetobacter baumannii MAR13-1452 (K125). The presence of rare deoxy amino sugars and the exclusive 1,2-cis glycosidic linkages within the tetrasaccharide make its synthesis more challenging. A one-pot oligosaccharide assembly enabled efficient and facile synthesis of the target molecule.
- 17 June 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (25) , 6855-6861
Total Synthesis of the Conjugation-Ready Tetrasaccharide Repeating Unit of Acinetobacter baumannii MAR13-1452 (K125) Capsular Polysaccharide for Vaccine Development
Acinetobacter baumannii is a highly drug-resistant pathogen that causes severe hospital infections and urgently requires new treatment strategies. Surface-exposed glycans of these bacteria have emerged as promising vaccine targets due to their immunogenic potential. Here, we report the first total synthesis of the tetrasaccharide repeating unit of Acinetobacter baumannii MAR13-1452 (K125). The presence of rare deoxy amino sugars and the exclusive 1,2-cis glycosidic linkages within the tetrasaccharide make its synthesis more challenging. A one-pot oligosaccharide assembly enabled efficient and facile synthesis of the target molecule.
- 2 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (23) , 12338-12346
Dual-Modulation Design to Develop ER-Targeting NIR Pyroptosis Inducers with Type I PDT Efficacy and Amplified Antitumor Immunity
Recently, immunogenic cell death (ICD) activated by phototherapy has attracted increasing attention in anticancer immunotherapy. Pyroptosis, a lysogenic and inflammatory form of cell death distinct from apoptosis, is considered to enhance the ICD process in tumor cells. Endoplasmic reticulum (ER)-targeted pyroptosis induced by phototherapy is reported to promote the release of inflammatory cytokines and DAMPs and amplify ICD response as a result. However, specific and stable tracking of the ER is more difficult than that of other organelles. In this work, we introduce a dual-modulation strategy to regulate the effect of ER-targeting unit p-toluenesulfonamide and twisting conjugation motif on the modification of heptamethine cyanine. A dimer dye (T780T-ER) with twisting structure and four p-toluenesulfonamide molecules is ultimately optimized, which can specifically target ER with good stability and efficient Type I PDT capability. Under PDT/PTT stimulation, T780T-ER activates sufficient pyroptosis and causes the release of inflammatory cytokines and DAMPs. In vivo, promoted ICD response and strengthened antitumor immunity are confirmed against the growth of primary and distant tumors. Summarily, this study highlights the importance of a multiple-modulation strategy in developing ER-targeted photosensitizers and proposes a Type I PDT molecule (T780T-ER) as an ER stress-dependent pyroptosis inducer to enhance antitumor immunotherapy.
- 2 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (23) , 12338-12346
Dual-Modulation Design to Develop ER-Targeting NIR Pyroptosis Inducers with Type I PDT Efficacy and Amplified Antitumor Immunity
Recently, immunogenic cell death (ICD) activated by phototherapy has attracted increasing attention in anticancer immunotherapy. Pyroptosis, a lysogenic and inflammatory form of cell death distinct from apoptosis, is considered to enhance the ICD process in tumor cells. Endoplasmic reticulum (ER)-targeted pyroptosis induced by phototherapy is reported to promote the release of inflammatory cytokines and DAMPs and amplify ICD response as a result. However, specific and stable tracking of the ER is more difficult than that of other organelles. In this work, we introduce a dual-modulation strategy to regulate the effect of ER-targeting unit p-toluenesulfonamide and twisting conjugation motif on the modification of heptamethine cyanine. A dimer dye (T780T-ER) with twisting structure and four p-toluenesulfonamide molecules is ultimately optimized, which can specifically target ER with good stability and efficient Type I PDT capability. Under PDT/PTT stimulation, T780T-ER activates sufficient pyroptosis and causes the release of inflammatory cytokines and DAMPs. In vivo, promoted ICD response and strengthened antitumor immunity are confirmed against the growth of primary and distant tumors. Summarily, this study highlights the importance of a multiple-modulation strategy in developing ER-targeted photosensitizers and proposes a Type I PDT molecule (T780T-ER) as an ER stress-dependent pyroptosis inducer to enhance antitumor immunotherapy.
- 28 October 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 197, 107069
A whole genome sequencing-based assay to investigate antibiotic susceptibility and strain lineage of Helicobacter pylori
- 28 October 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 197, 107069
A whole genome sequencing-based assay to investigate antibiotic susceptibility and strain lineage of Helicobacter pylori
Cascaded Nanozyme Based pH‐Responsive Oxygenation for Targeted Eradication of Resistant Helicobacter Pylori
Nanozymes, as substitutes for natural enzymes, are constructed as cascade catalysis systems for biomedical applications due to their inherent catalytic properties, high stability, tunable physicochemical properties, and environmental responsiveness. Herein, a multifunctional nanozyme is reported to initiate cascade enzymatic reactions specific in acidic environments for resistant Helicobacter pylori (H. pylori) targeting eradication. The cobalt‐coated Prussian blue analog based FPB‐Co‐Ch NPs displays oxidase‐, superoxide dismutase‐, peroxidase‐, and catalase‐ mimicking activities that trigger • and H2O2 to supply O2, thereby killing H. pylori in the stomach. To this end, chitosan is modified on the surface to exert bacterial targeted adhesion and improve the biocompatibility of the composite. In the intestinal environment, the cascade enzymatic activities are significantly inhibited, ensuring the biosafety of the treatment. In vitro, sensitive and resistant strains of H. pylori are cultured and the antibacterial activity is evaluated. In vivo, murine infection models are developed and its success is confirmed by gastric mucosal reculturing, Gram staining, H&E staining, and Giemsa staining. Additionally, the antibacterial capacity, anti‐inflammation, repair effects, and biosafety of FPB‐Co‐Ch NPs are comprehensively investigated. This strategy renders a drug‐free approach that specifically targets and kills H. pylori, restoring the damaged gastric mucosa while relieving inflammation.
Cascaded Nanozyme Based pH‐Responsive Oxygenation for Targeted Eradication of Resistant Helicobacter Pylori
Nanozymes, as substitutes for natural enzymes, are constructed as cascade catalysis systems for biomedical applications due to their inherent catalytic properties, high stability, tunable physicochemical properties, and environmental responsiveness. Herein, a multifunctional nanozyme is reported to initiate cascade enzymatic reactions specific in acidic environments for resistant Helicobacter pylori (H. pylori) targeting eradication. The cobalt‐coated Prussian blue analog based FPB‐Co‐Ch NPs displays oxidase‐, superoxide dismutase‐, peroxidase‐, and catalase‐ mimicking activities that trigger • and H2O2 to supply O2, thereby killing H. pylori in the stomach. To this end, chitosan is modified on the surface to exert bacterial targeted adhesion and improve the biocompatibility of the composite. In the intestinal environment, the cascade enzymatic activities are significantly inhibited, ensuring the biosafety of the treatment. In vitro, sensitive and resistant strains of H. pylori are cultured and the antibacterial activity is evaluated. In vivo, murine infection models are developed and its success is confirmed by gastric mucosal reculturing, Gram staining, H&E staining, and Giemsa staining. Additionally, the antibacterial capacity, anti‐inflammation, repair effects, and biosafety of FPB‐Co‐Ch NPs are comprehensively investigated. This strategy renders a drug‐free approach that specifically targets and kills H. pylori, restoring the damaged gastric mucosa while relieving inflammation.
- 28 March 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (14) , 17891-17903
Template-Free Self-Assembly of Hollow Microtubular Covalent Organic Frameworks for Oral Delivery of Insulin
Covalent organic frameworks (COFs) have demonstrated versatile application potential since their discovery. Although the structure of COFs is orderly arranged, the synthesis of controllable macrostructures still faces challenges. Herein, we report, to our knowledge, the first template-free self-assembled COF-18 Å hollow microtubule (MT-COF-18 Å) structure and its use for insulin delivery that exhibits high loading capacity, gastroresistance, and glucose-responsive properties. The hollow MT-COF-18 Å was achieved by a template-free method benefiting from the mixed solvents of mesitylene and dioxane. The formation mechanism and morphology changes with insulin loading and release were observed. In Caco-2 cells, the transferrin-coated system demonstrated enhanced insulin cellular uptake and transcellular transport, which indicated great potential for oral applications. Additionally, the composites presented sustained glycemic control and effective insulin blood concentrations without noticeable toxicity in diabetic rats. This work shows that hollow microtubular COFs hold great promise in loading and delivery of biomolecules.
- 28 March 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (14) , 17891-17903
Template-Free Self-Assembly of Hollow Microtubular Covalent Organic Frameworks for Oral Delivery of Insulin
Covalent organic frameworks (COFs) have demonstrated versatile application potential since their discovery. Although the structure of COFs is orderly arranged, the synthesis of controllable macrostructures still faces challenges. Herein, we report, to our knowledge, the first template-free self-assembled COF-18 Å hollow microtubule (MT-COF-18 Å) structure and its use for insulin delivery that exhibits high loading capacity, gastroresistance, and glucose-responsive properties. The hollow MT-COF-18 Å was achieved by a template-free method benefiting from the mixed solvents of mesitylene and dioxane. The formation mechanism and morphology changes with insulin loading and release were observed. In Caco-2 cells, the transferrin-coated system demonstrated enhanced insulin cellular uptake and transcellular transport, which indicated great potential for oral applications. Additionally, the composites presented sustained glycemic control and effective insulin blood concentrations without noticeable toxicity in diabetic rats. This work shows that hollow microtubular COFs hold great promise in loading and delivery of biomolecules.